Aadi Bioscience Inc (NAS:AADI)
$ 1.99 0.03 (1.53%) Market Cap: 48.98 Mil Enterprise Value: -29.27 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 42/100

Q4 2022 Aadi Bioscience Inc Earnings Call Transcript

Mar 28, 2023 / 12:30PM GMT
Release Date Price: $6.85 (-5.52%)
Operator

Good day, and thank you for standing by. Welcome to the Aadi Bioscience Fourth Quarter 2022 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

Now I will turn the call over to Marcy Graham, Senior Vice President of Investor Relations and Corporate Communications at Aadi Bioscience. Ms. Graham, please go ahead.

Marcy Graham
Aadi Bioscience, Inc. - SVP of IR & Corporate Communications

Thank you, Elizabeth. Good morning, and welcome to the Aadi Bioscience conference call to review results of the fourth quarter and full year 2022 and to provide an update on our operations since the start of 2023.

Joining me on the call today is Scott Giacobello, our CFO and Interim President and CEO, who will provide an overview of financial and operational activity during the period, including an update on our continued commercial progress. Next will be our Chief Medical Officer, Dr. Loretta Itri, who will provide insights on our clinical developments and plans for 2023. We will open the line for questions at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot